Compared with HCs, IgG responses induced by CD19+ B cells in the presence of CD16+ (P < 0.05) and CD16− (P < 0.01) subsets were significantly exacerbated in patients with SLE. The gene discussed is CD19; the disease is systemic lupus erythematosus.